Skip to main content
Article
P-242International prospective multi-center clinical trial with adherence to surgical and pathological quality measures: Influence of body mass index (BMI) on outcome in colon cancer
Annals of Oncology (2018)
  • M Protic, University of Novi Sad
  • A Bilchik, John Wayne Cancer Institute, Santa Monica, California, USA
  • A Nissan, Sheba Medical Center
  • S Usaj Knezevic, Univerisity of Novi Sad - Faculty of Medicine and Oncology Institute of Vojvodina, Novi Sad, Serbia
  • B Kukic, Univerisity of Novi Sad - Faculty of Medicine and Oncology Institute of Vojvodina, Novi Sad, Serbia
  • M Kresoja, Univerisity of Novi Sad - Faculty of Medicine and Oncology Institute of Vojvodina, Novi Sad, Serbia
  • R Veljkovic, University of Novi Sad
  • M Zivojinov, University of Novi Sad
  • A Stojadinovic, Uniformed Services University of the Health Sciences
Publication Date
June 1, 2018
DOI
10.1093/annonc/mdy151.241
Citation Information
M Protic, A Bilchik, A Nissan, S Usaj Knezevic, et al.. "P-242International prospective multi-center clinical trial with adherence to surgical and pathological quality measures: Influence of body mass index (BMI) on outcome in colon cancer" Annals of Oncology Vol. 29 (2018)
Available at: http://works.bepress.com/antonj-bilchik/6/